LF-20-0383

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameLF-20-0383
Drug Alias NameLF-216
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-8 receptors antagonists
TargetsInterleukin-8 receptors
Therapy Area/IndicationsRespiratory Distress Syndrome, AdultPulmonary Disease, Chronic ObstructiveArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFournier Pharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFournier Pharma Corp
Active IndicationsN/A
Inactive IndicationsRespiratory Distress Syndrome, AdultPulmonary Disease, Chronic ObstructiveArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A